Global Gliclazide Sustained-release Tablet Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 06 Apr 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Gliclazide Sustained-release Tablet market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Gliclazide Sustained-release Tablet production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gliclazide Sustained-release Tablet, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gliclazide Sustained-release Tablet that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gliclazide Sustained-release Tablet total production and demand, 2018-2029, (K Units)
Global Gliclazide Sustained-release Tablet total production value, 2018-2029, (USD Million)
Global Gliclazide Sustained-release Tablet production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gliclazide Sustained-release Tablet domestic production, consumption, key domestic manufacturers and share
Global Gliclazide Sustained-release Tablet production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Gliclazide Sustained-release Tablet market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare and Lukang Jituan Saite Yaoye, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gliclazide Sustained-release Tablet market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gliclazide Sustained-release Tablet Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gliclazide Sustained-release Tablet Market, Segmentation by Type
    30mg
    60mg
    Other

Global Gliclazide Sustained-release Tablet Market, Segmentation by Application
    Hospital
    Clinic
    Other

Companies Profiled:
    Servier Laboratories
    Torrent Pharmaceuticals
    Aurobindo Pharma
    Teva
    Zydus Cadila Healthcare
    Sanofi S.A.
    Mylan Pharmaceuticals
    Accord Healthcare
    Lukang Jituan Saite Yaoye
    Shijiazhuang SIYAO
    Yiling Pharmaceutical

Key Questions Answered
1. How big is the global Gliclazide Sustained-release Tablet market?
2. What is the demand of the global Gliclazide Sustained-release Tablet market?
3. What is the year over year growth of the global Gliclazide Sustained-release Tablet market?
4. What is the production and production value of the global Gliclazide Sustained-release Tablet market?
5. Who are the key producers in the global Gliclazide Sustained-release Tablet market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gliclazide Sustained-release Tablet Introduction
    1.2 World Gliclazide Sustained-release Tablet Supply & Forecast
        1.2.1 World Gliclazide Sustained-release Tablet Production Value (2018 & 2022 & 2029)
        1.2.2 World Gliclazide Sustained-release Tablet Production (2018-2029)
        1.2.3 World Gliclazide Sustained-release Tablet Pricing Trends (2018-2029)
    1.3 World Gliclazide Sustained-release Tablet Production by Region (Based on Production Site)
        1.3.1 World Gliclazide Sustained-release Tablet Production Value by Region (2018-2029)
        1.3.2 World Gliclazide Sustained-release Tablet Production by Region (2018-2029)
        1.3.3 World Gliclazide Sustained-release Tablet Average Price by Region (2018-2029)
        1.3.4 North America Gliclazide Sustained-release Tablet Production (2018-2029)
        1.3.5 Europe Gliclazide Sustained-release Tablet Production (2018-2029)
        1.3.6 China Gliclazide Sustained-release Tablet Production (2018-2029)
        1.3.7 Japan Gliclazide Sustained-release Tablet Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gliclazide Sustained-release Tablet Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gliclazide Sustained-release Tablet Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gliclazide Sustained-release Tablet Demand (2018-2029)
    2.2 World Gliclazide Sustained-release Tablet Consumption by Region
        2.2.1 World Gliclazide Sustained-release Tablet Consumption by Region (2018-2023)
        2.2.2 World Gliclazide Sustained-release Tablet Consumption Forecast by Region (2024-2029)
    2.3 United States Gliclazide Sustained-release Tablet Consumption (2018-2029)
    2.4 China Gliclazide Sustained-release Tablet Consumption (2018-2029)
    2.5 Europe Gliclazide Sustained-release Tablet Consumption (2018-2029)
    2.6 Japan Gliclazide Sustained-release Tablet Consumption (2018-2029)
    2.7 South Korea Gliclazide Sustained-release Tablet Consumption (2018-2029)
    2.8 ASEAN Gliclazide Sustained-release Tablet Consumption (2018-2029)
    2.9 India Gliclazide Sustained-release Tablet Consumption (2018-2029)

3 World Gliclazide Sustained-release Tablet Manufacturers Competitive Analysis
    3.1 World Gliclazide Sustained-release Tablet Production Value by Manufacturer (2018-2023)
    3.2 World Gliclazide Sustained-release Tablet Production by Manufacturer (2018-2023)
    3.3 World Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023)
    3.4 Gliclazide Sustained-release Tablet Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Gliclazide Sustained-release Tablet Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Gliclazide Sustained-release Tablet in 2022
        3.5.3 Global Concentration Ratios (CR8) for Gliclazide Sustained-release Tablet in 2022
    3.6 Gliclazide Sustained-release Tablet Market: Overall Company Footprint Analysis
        3.6.1 Gliclazide Sustained-release Tablet Market: Region Footprint
        3.6.2 Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
        3.6.3 Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Gliclazide Sustained-release Tablet Production Value Comparison
        4.1.1 United States VS China: Gliclazide Sustained-release Tablet Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Gliclazide Sustained-release Tablet Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Gliclazide Sustained-release Tablet Production Comparison
        4.2.1 United States VS China: Gliclazide Sustained-release Tablet Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gliclazide Sustained-release Tablet Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Gliclazide Sustained-release Tablet Consumption Comparison
        4.3.1 United States VS China: Gliclazide Sustained-release Tablet Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Gliclazide Sustained-release Tablet Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Gliclazide Sustained-release Tablet Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
    4.5 China Based Gliclazide Sustained-release Tablet Manufacturers and Market Share
        4.5.1 China Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
        4.5.3 China Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
    4.6 Rest of World Based Gliclazide Sustained-release Tablet Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)

5 Market Analysis by Type
    5.1 World Gliclazide Sustained-release Tablet Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 30mg
        5.2.2 60mg
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Gliclazide Sustained-release Tablet Production by Type (2018-2029)
        5.3.2 World Gliclazide Sustained-release Tablet Production Value by Type (2018-2029)
        5.3.3 World Gliclazide Sustained-release Tablet Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gliclazide Sustained-release Tablet Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Gliclazide Sustained-release Tablet Production by Application (2018-2029)
        6.3.2 World Gliclazide Sustained-release Tablet Production Value by Application (2018-2029)
        6.3.3 World Gliclazide Sustained-release Tablet Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Servier Laboratories
        7.1.1 Servier Laboratories Details
        7.1.2 Servier Laboratories Major Business
        7.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
        7.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Servier Laboratories Recent Developments/Updates
        7.1.6 Servier Laboratories Competitive Strengths & Weaknesses
    7.2 Torrent Pharmaceuticals
        7.2.1 Torrent Pharmaceuticals Details
        7.2.2 Torrent Pharmaceuticals Major Business
        7.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
        7.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
        7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Aurobindo Pharma
        7.3.1 Aurobindo Pharma Details
        7.3.2 Aurobindo Pharma Major Business
        7.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
        7.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Aurobindo Pharma Recent Developments/Updates
        7.3.6 Aurobindo Pharma Competitive Strengths & Weaknesses
    7.4 Teva
        7.4.1 Teva Details
        7.4.2 Teva Major Business
        7.4.3 Teva Gliclazide Sustained-release Tablet Product and Services
        7.4.4 Teva Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Teva Recent Developments/Updates
        7.4.6 Teva Competitive Strengths & Weaknesses
    7.5 Zydus Cadila Healthcare
        7.5.1 Zydus Cadila Healthcare Details
        7.5.2 Zydus Cadila Healthcare Major Business
        7.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
        7.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Zydus Cadila Healthcare Recent Developments/Updates
        7.5.6 Zydus Cadila Healthcare Competitive Strengths & Weaknesses
    7.6 Sanofi S.A.
        7.6.1 Sanofi S.A. Details
        7.6.2 Sanofi S.A. Major Business
        7.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
        7.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Sanofi S.A. Recent Developments/Updates
        7.6.6 Sanofi S.A. Competitive Strengths & Weaknesses
    7.7 Mylan Pharmaceuticals
        7.7.1 Mylan Pharmaceuticals Details
        7.7.2 Mylan Pharmaceuticals Major Business
        7.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
        7.7.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Mylan Pharmaceuticals Recent Developments/Updates
        7.7.6 Mylan Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Accord Healthcare
        7.8.1 Accord Healthcare Details
        7.8.2 Accord Healthcare Major Business
        7.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
        7.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Accord Healthcare Recent Developments/Updates
        7.8.6 Accord Healthcare Competitive Strengths & Weaknesses
    7.9 Lukang Jituan Saite Yaoye
        7.9.1 Lukang Jituan Saite Yaoye Details
        7.9.2 Lukang Jituan Saite Yaoye Major Business
        7.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
        7.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
        7.9.6 Lukang Jituan Saite Yaoye Competitive Strengths & Weaknesses
    7.10 Shijiazhuang SIYAO
        7.10.1 Shijiazhuang SIYAO Details
        7.10.2 Shijiazhuang SIYAO Major Business
        7.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
        7.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Shijiazhuang SIYAO Recent Developments/Updates
        7.10.6 Shijiazhuang SIYAO Competitive Strengths & Weaknesses
    7.11 Yiling Pharmaceutical
        7.11.1 Yiling Pharmaceutical Details
        7.11.2 Yiling Pharmaceutical Major Business
        7.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
        7.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Yiling Pharmaceutical Recent Developments/Updates
        7.11.6 Yiling Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gliclazide Sustained-release Tablet Industry Chain
    8.2 Gliclazide Sustained-release Tablet Upstream Analysis
        8.2.1 Gliclazide Sustained-release Tablet Core Raw Materials
        8.2.2 Main Manufacturers of Gliclazide Sustained-release Tablet Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Gliclazide Sustained-release Tablet Production Mode
    8.6 Gliclazide Sustained-release Tablet Procurement Model
    8.7 Gliclazide Sustained-release Tablet Industry Sales Model and Sales Channels
        8.7.1 Gliclazide Sustained-release Tablet Sales Model
        8.7.2 Gliclazide Sustained-release Tablet Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gliclazide Sustained-release Tablet Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Gliclazide Sustained-release Tablet Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Gliclazide Sustained-release Tablet Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2018-2023)
    Table 5. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2024-2029)
    Table 6. World Gliclazide Sustained-release Tablet Production by Region (2018-2023) & (K Units)
    Table 7. World Gliclazide Sustained-release Tablet Production by Region (2024-2029) & (K Units)
    Table 8. World Gliclazide Sustained-release Tablet Production Market Share by Region (2018-2023)
    Table 9. World Gliclazide Sustained-release Tablet Production Market Share by Region (2024-2029)
    Table 10. World Gliclazide Sustained-release Tablet Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Gliclazide Sustained-release Tablet Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Gliclazide Sustained-release Tablet Major Market Trends
    Table 13. World Gliclazide Sustained-release Tablet Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Gliclazide Sustained-release Tablet Consumption by Region (2018-2023) & (K Units)
    Table 15. World Gliclazide Sustained-release Tablet Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Gliclazide Sustained-release Tablet Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Gliclazide Sustained-release Tablet Producers in 2022
    Table 18. World Gliclazide Sustained-release Tablet Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Gliclazide Sustained-release Tablet Producers in 2022
    Table 20. World Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Gliclazide Sustained-release Tablet Company Evaluation Quadrant
    Table 22. World Gliclazide Sustained-release Tablet Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Gliclazide Sustained-release Tablet Production Site of Key Manufacturer
    Table 24. Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
    Table 25. Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
    Table 26. Gliclazide Sustained-release Tablet Competitive Factors
    Table 27. Gliclazide Sustained-release Tablet New Entrant and Capacity Expansion Plans
    Table 28. Gliclazide Sustained-release Tablet Mergers & Acquisitions Activity
    Table 29. United States VS China Gliclazide Sustained-release Tablet Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Gliclazide Sustained-release Tablet Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Gliclazide Sustained-release Tablet Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
    Table 37. China Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
    Table 42. Rest of World Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
    Table 47. World Gliclazide Sustained-release Tablet Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Gliclazide Sustained-release Tablet Production by Type (2018-2023) & (K Units)
    Table 49. World Gliclazide Sustained-release Tablet Production by Type (2024-2029) & (K Units)
    Table 50. World Gliclazide Sustained-release Tablet Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Gliclazide Sustained-release Tablet Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Gliclazide Sustained-release Tablet Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Gliclazide Sustained-release Tablet Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Gliclazide Sustained-release Tablet Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Gliclazide Sustained-release Tablet Production by Application (2018-2023) & (K Units)
    Table 56. World Gliclazide Sustained-release Tablet Production by Application (2024-2029) & (K Units)
    Table 57. World Gliclazide Sustained-release Tablet Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Gliclazide Sustained-release Tablet Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Gliclazide Sustained-release Tablet Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Gliclazide Sustained-release Tablet Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Servier Laboratories Basic Information, Manufacturing Base and Competitors
    Table 62. Servier Laboratories Major Business
    Table 63. Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
    Table 64. Servier Laboratories Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Servier Laboratories Recent Developments/Updates
    Table 66. Servier Laboratories Competitive Strengths & Weaknesses
    Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 68. Torrent Pharmaceuticals Major Business
    Table 69. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
    Table 70. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Torrent Pharmaceuticals Recent Developments/Updates
    Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
    Table 73. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
    Table 74. Aurobindo Pharma Major Business
    Table 75. Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
    Table 76. Aurobindo Pharma Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Aurobindo Pharma Recent Developments/Updates
    Table 78. Aurobindo Pharma Competitive Strengths & Weaknesses
    Table 79. Teva Basic Information, Manufacturing Base and Competitors
    Table 80. Teva Major Business
    Table 81. Teva Gliclazide Sustained-release Tablet Product and Services
    Table 82. Teva Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Teva Recent Developments/Updates
    Table 84. Teva Competitive Strengths & Weaknesses
    Table 85. Zydus Cadila Healthcare Basic Information, Manufacturing Base and Competitors
    Table 86. Zydus Cadila Healthcare Major Business
    Table 87. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
    Table 88. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Zydus Cadila Healthcare Recent Developments/Updates
    Table 90. Zydus Cadila Healthcare Competitive Strengths & Weaknesses
    Table 91. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
    Table 92. Sanofi S.A. Major Business
    Table 93. Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
    Table 94. Sanofi S.A. Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Sanofi S.A. Recent Developments/Updates
    Table 96. Sanofi S.A. Competitive Strengths & Weaknesses
    Table 97. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 98. Mylan Pharmaceuticals Major Business
    Table 99. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
    Table 100. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Mylan Pharmaceuticals Recent Developments/Updates
    Table 102. Mylan Pharmaceuticals Competitive Strengths & Weaknesses
    Table 103. Accord Healthcare Basic Information, Manufacturing Base and Competitors
    Table 104. Accord Healthcare Major Business
    Table 105. Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
    Table 106. Accord Healthcare Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Accord Healthcare Recent Developments/Updates
    Table 108. Accord Healthcare Competitive Strengths & Weaknesses
    Table 109. Lukang Jituan Saite Yaoye Basic Information, Manufacturing Base and Competitors
    Table 110. Lukang Jituan Saite Yaoye Major Business
    Table 111. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
    Table 112. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Lukang Jituan Saite Yaoye Recent Developments/Updates
    Table 114. Lukang Jituan Saite Yaoye Competitive Strengths & Weaknesses
    Table 115. Shijiazhuang SIYAO Basic Information, Manufacturing Base and Competitors
    Table 116. Shijiazhuang SIYAO Major Business
    Table 117. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
    Table 118. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Shijiazhuang SIYAO Recent Developments/Updates
    Table 120. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 121. Yiling Pharmaceutical Major Business
    Table 122. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
    Table 123. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Gliclazide Sustained-release Tablet Upstream (Raw Materials)
    Table 125. Gliclazide Sustained-release Tablet Typical Customers
    Table 126. Gliclazide Sustained-release Tablet Typical Distributors
List of Figure
    Figure 1. Gliclazide Sustained-release Tablet Picture
    Figure 2. World Gliclazide Sustained-release Tablet Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gliclazide Sustained-release Tablet Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
    Figure 5. World Gliclazide Sustained-release Tablet Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2018-2029)
    Figure 7. World Gliclazide Sustained-release Tablet Production Market Share by Region (2018-2029)
    Figure 8. North America Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
    Figure 9. Europe Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
    Figure 10. China Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
    Figure 11. Japan Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
    Figure 12. Gliclazide Sustained-release Tablet Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 15. World Gliclazide Sustained-release Tablet Consumption Market Share by Region (2018-2029)
    Figure 16. United States Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 17. China Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 18. Europe Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 19. Japan Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 22. India Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Gliclazide Sustained-release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Gliclazide Sustained-release Tablet Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Gliclazide Sustained-release Tablet Markets in 2022
    Figure 26. United States VS China: Gliclazide Sustained-release Tablet Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Gliclazide Sustained-release Tablet Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gliclazide Sustained-release Tablet Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
    Figure 30. China Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
    Figure 32. World Gliclazide Sustained-release Tablet Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Gliclazide Sustained-release Tablet Production Value Market Share by Type in 2022
    Figure 34. 30mg
    Figure 35. 60mg
    Figure 36. Other
    Figure 37. World Gliclazide Sustained-release Tablet Production Market Share by Type (2018-2029)
    Figure 38. World Gliclazide Sustained-release Tablet Production Value Market Share by Type (2018-2029)
    Figure 39. World Gliclazide Sustained-release Tablet Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Gliclazide Sustained-release Tablet Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Gliclazide Sustained-release Tablet Production Value Market Share by Application in 2022
    Figure 42. Hospital
    Figure 43. Clinic
    Figure 44. Other
    Figure 45. World Gliclazide Sustained-release Tablet Production Market Share by Application (2018-2029)
    Figure 46. World Gliclazide Sustained-release Tablet Production Value Market Share by Application (2018-2029)
    Figure 47. World Gliclazide Sustained-release Tablet Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Gliclazide Sustained-release Tablet Industry Chain
    Figure 49. Gliclazide Sustained-release Tablet Procurement Model
    Figure 50. Gliclazide Sustained-release Tablet Sales Model
    Figure 51. Gliclazide Sustained-release Tablet Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Gliclazide Sustained-release Tablet Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Gliclazide Sustained-release Tablet Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Apr 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gliclazide Sustained-release Tablet market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Gliclazide Sustained-release Tablet Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Gliclazide Sustained-release Tablet Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 20 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gliclazide Sustained-release Tablet market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Gliclazide Sustained-release Tablet

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>